Meeting
2018 ASCO Annual Meeting
What is the prognostic impact of BRAF mutation in patients undergoing resection of colorectal liver metastases? Results of nationwide intergroup (ACHBT, FRENCH, AGEO) cohort of 249 patients.
Authors
Jean-Baptiste Bachet
Hospital Pitié-Salpêtrière, Paris, France
Jean-Baptiste Bachet , Nathan Moreno-Lopez , Luca Viganò , Ugo Marchese , Maximiliano Gelli , Loic Raoux , Stephanie Truant , Christophe Laurent , Astrid Herrero , Bertrand Le Roy , Sophie Deguelte Lardiere , Guillaume Passot , Vincent Hautefeuille , Christelle De La Fouchardiere , Pascal Artru , Tchalla Ameto , Antoine Brouquet , Antonio Sa Cunha , Stéphane Benoist
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 36, 2018 (suppl; abstr 3554)
DOI
10.1200/JCO.2018.36.15_suppl.3554
Abstract #
3554
Poster Bd #
47
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Clinical and molecular characterization of patients with metastatic colorectal cancer harbouring DNA mismatch repair deficiency.
First Author: Romain Cohen
Poster
2012 ASCO Annual Meeting
Incidence and prognostic impact of KRAS and BRAF mutations in patients undergoing liver surgery for colorectal metastases.
First Author: Georgios Karagkounis
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Clinical evolution after surgery of hepatic metastases of colorectal cancer according to genomic profile.
First Author: Blanca Morón García
Poster
2021 ASCO Annual Meeting
The prognostic impact of RAS and TP53 mutation according to primary tumor location in colorectal liver metastases.
First Author: Yongjun Cha